Bbva Compass Bancshares Inc. increased its position in Varian Medical Systems Inc. (NYSE:VAR) by 0.1% during the third quarter, Holdings Channel reports. The institutional investor owned 58,230 shares of the company’s stock after buying an additional 53 shares during the period. Bbva Compass Bancshares Inc.’s holdings in Varian Medical Systems were worth $5,795,000 as of its most recent filing with the SEC.

Other hedge funds also recently modified their holdings of the company. First Eagle Investment Management LLC boosted its stake in shares of Varian Medical Systems by 35.3% in the second quarter. First Eagle Investment Management LLC now owns 4,325,749 shares of the company’s stock worth $355,706,000 after buying an additional 1,128,626 shares in the last quarter. Emerald Acquisition Ltd. bought a new stake in shares of Varian Medical Systems during the second quarter worth approximately $43,974,000. Loomis Sayles & Co. L P boosted its stake in shares of Varian Medical Systems by 8.7% in the second quarter. Loomis Sayles & Co. L P now owns 5,903,578 shares of the company’s stock worth $485,451,000 after buying an additional 474,506 shares in the last quarter. Nordea Investment Management AB boosted its stake in shares of Varian Medical Systems by 287.4% in the second quarter. Nordea Investment Management AB now owns 590,879 shares of the company’s stock worth $48,588,000 after buying an additional 438,348 shares in the last quarter. Finally, BlackRock Fund Advisors boosted its stake in shares of Varian Medical Systems by 12.6% in the second quarter. BlackRock Fund Advisors now owns 3,183,332 shares of the company’s stock worth $261,765,000 after buying an additional 357,316 shares in the last quarter. 99.83% of the stock is currently owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Varian Medical Systems Inc. (NYSE:VAR) traded down 1.67% during midday trading on Wednesday, hitting $89.83. The stock had a trading volume of 848,428 shares. Varian Medical Systems Inc. has a 52-week low of $73.18 and a 52-week high of $106.70. The firm has a market capitalization of $8.39 billion, a P/E ratio of 21.44 and a beta of 0.67. The firm has a 50-day moving average of $92.39 and a 200 day moving average of $90.54.

Varian Medical Systems (NYSE:VAR) last issued its quarterly earnings data on Wednesday, October 26th. The company reported $1.38 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.34 by $0.04. The company had revenue of $912 million for the quarter, compared to analyst estimates of $880.29 million. Varian Medical Systems had a net margin of 12.51% and a return on equity of 26.57%. Varian Medical Systems’s revenue was up 11.5% compared to the same quarter last year. During the same period last year, the company posted $1.04 earnings per share. On average, equities analysts forecast that Varian Medical Systems Inc. will post $4.93 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “Varian Medical Systems Inc. (VAR) Stake Increased by Bbva Compass Bancshares Inc.” was first published by Daily Political and is owned by of Daily Political. If you are reading this news story on another domain, it was illegally copied and republished in violation of United States and international copyright and trademark legislation. The original version of this news story can be accessed at http://www.dailypolitical.com/2016/11/30/varian-medical-systems-inc-var-stake-increased-by-bbva-compass-bancshares-inc.html.

Several equities analysts recently issued reports on the company. Zacks Investment Research cut Varian Medical Systems from a “buy” rating to a “hold” rating in a research report on Tuesday, October 25th. Robert W. Baird upped their price objective on Varian Medical Systems from $91.00 to $99.00 and gave the company a “neutral” rating in a research report on Wednesday, September 28th. BTIG Research reaffirmed a “hold” rating on shares of Varian Medical Systems in a research report on Monday, October 31st. Finally, Jefferies Group reaffirmed a “buy” rating and issued a $98.00 price objective on shares of Varian Medical Systems in a research report on Wednesday, September 28th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the company. The company currently has a consensus rating of “Hold” and an average target price of $93.38.

In related news, insider Dow R. Wilson sold 10,000 shares of Varian Medical Systems stock in a transaction that occurred on Tuesday, September 6th. The shares were sold at an average price of $96.08, for a total transaction of $960,800.00. Following the transaction, the insider now directly owns 70,598 shares of the company’s stock, valued at $6,783,055.84. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Elisha W. Finney sold 2,000 shares of Varian Medical Systems stock in a transaction that occurred on Thursday, September 1st. The shares were sold at an average price of $95.82, for a total transaction of $191,640.00. Following the transaction, the chief financial officer now directly owns 7,195 shares in the company, valued at $689,424.90. The disclosure for this sale can be found here. Corporate insiders own 0.86% of the company’s stock.

Varian Medical Systems Company Profile

Varian Medical Systems Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection.

5 Day Chart for NYSE:VAR

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems Inc. (NYSE:VAR).

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.